Markets may see action across pharma, IT and infrastructure stocks. Stake sales, acquisitions, regulatory updates and AI-led initiatives could drive stock-specific movement on D-Street.

KalVista Pharmaceuticals sees its Relative Strength Rating enter the 80-plus level.

Synopsis: Cupid Limited is developing nitrile female condoms to enter a high-demand global market, boosting capacity and targeting a premium segment with higher margins and strong ...

NervGen Pharma Corp. NVG-291 shows lasting gains in chronic spinal cord injury; Phase 3 and FDA fast paths ahead. Click for this NGEN update.

The company's pipeline features almost 40 programs in late-stage clinical testing. These clinical trials are testing new drug candidates and seeking additional approvals for drugs such as Tremfya.

In this article, we will be taking a look at the 7 Oversold Pharma Stocks to Buy Now. In 2024, the pharmaceutical sector in the United States was valued at $634.32 billion, and by 2030, it is expected ...

Discover the key financial ratios vital for evaluating pharmaceutical stocks, essential for making informed investment decisions in this unique industry.

Over the next 5 years, Gland Pharma plans to invest approximately Rs 20 bn in capex, primarily towards BFS and ophthalmic ...